BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16795974)

  • 1. Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma.
    Kunisaki C; Imada T; Yamada R; Hatori S; Kinbara K; Watai K; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
    Hepatogastroenterology; 2006; 53(69):366-71. PubMed ID: 16795974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
    Makino T; Yamasaki M; Miyata H; Yoshioka S; Takiguchi S; Fujiwara Y; Nakajima K; Nishida T; Mori M; Doki Y
    Ann Surg Oncol; 2010 Mar; 17(3):804-11. PubMed ID: 19885698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
    Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
    J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
    Fujita H; Sueyoshi S; Tanaka T; Tanaka Y; Sasahara H; Shirouzu K; Suzuki G; Hayabuchi N; Inutsuka H
    J Surg Oncol; 2005 Jun; 90(4):209-19. PubMed ID: 15906363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
    Koike R; Nishimura Y; Nakamatsu K; Kanamori S; Shibata T
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1418-22. PubMed ID: 18234437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multivariate analysis of the prognostic and predictive factors of response to concomitant radiochemotherapy in epidermoid cancers of the esophagus. Value of immunodetection of protein p53].
    Seitz JF; Perrier H; Monges G; Giovannini M; Gouvernet J
    Gastroenterol Clin Biol; 1995 May; 19(5):465-74. PubMed ID: 7589997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases].
    Wang XS; Liu MZ; Zhang CQ; Cai L; Cui NJ
    Ai Zheng; 2006 Nov; 25(11):1428-32. PubMed ID: 17094915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens.
    Kii T; Takiuchi H; Kawabe S; Gotoh M; Ohta S; Tanaka T; Kuwakado S; Nishitani H; Katsu K
    Jpn J Clin Oncol; 2007 Aug; 37(8):583-9. PubMed ID: 17709606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemoradiotherapy with low-dose cisplatin and 5-FU for advanced esophageal cancer].
    Tajima M; Ichikawa W; Takagi Y; Uetake Y; Kojima K; Osanai T; Takenaka S; Nihei Z; Sugihara K
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1816-8. PubMed ID: 11086419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.
    Yamasaki M; Miyata H; Fujiwara Y; Takiguchi S; Nakajima K; Nishida T; Yasuda T; Matsuyama J; Mori M; Doki Y
    Ann Surg Oncol; 2010 Feb; 17(2):634-42. PubMed ID: 19941080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report.
    Fujiwara Y; Kamikonya N; Inoue T; Koishi K; Yoshikawa R; Nakao K; Yagyu R; Nishiwaki M; Fujiwara M; Kojima S; Nakagawa K; Yamamura T
    Oncol Rep; 2005 Nov; 14(5):1177-82. PubMed ID: 16211282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy.
    Wakatsuki M; Suzuki Y; Nakamoto S; Ohno T; Ishikawa H; Kiyohara H; Kiyozuka M; Shirai K; Nakayama Y; Nakano T
    J Gastroenterol Hepatol; 2007 May; 22(5):715-9. PubMed ID: 17444861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
    Warnecke-Eberz U; Hokita S; Xi H; Higashi H; Baldus SE; Metzger R; Brabender J; Bollschweiler E; Mueller RP; Dienes HP; Hoelscher AH; Schneider PM
    Oncol Rep; 2005 Jun; 13(6):1241-6. PubMed ID: 15870949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.
    Yamada K; Murakami M; Okamoto Y; Okuno Y; Nakajima T; Kusumi F; Takakuwa H; Matsusue S
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1106-11. PubMed ID: 16504758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Yano T; Muto M; Hattori S; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
    Endoscopy; 2008 Sep; 40(9):717-21. PubMed ID: 18773340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102.
    Crehange G; Maingon P; Peignaux K; N'guyen TD; Mirabel X; Marchal C; Verrelle P; Roullet B; Bonnetain F; Bedenne L;
    J Clin Oncol; 2007 Nov; 25(31):4895-901. PubMed ID: 17971585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
    Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.